Table 1.
HLA molecule and NY-ESO-1 expression of the cells used in this report
| Cell line | HLA-A | HLA-B | HLA-C | Serum Ab | ESO | |||
|---|---|---|---|---|---|---|---|---|
| Patient B01 | 02 | 68 | 39 | 51 | 05 | 12 | + | |
| Patient B02 | 02 | 44 | 51 | 05 | 15 | + | ||
| Patient B03 | 33 | 68 | 15 | 8101 | 0202 | 18 | + | |
| Patient B04 | 11 | 68 | 44 | 52 | 07 | 12 | − | |
| Patient B05 | 11 | 68 | 06 | 07 | − | |||
| Patient B06 | 26 | 29 | 44 | 51 | 16 | 15 | + | |
| B07 T-APC | 01 | 25 | 18 | 37 | 06 | 12 | ||
| B08 EBV-B | 0201 | 0101 | 1801 | 3701 | 0602 | 0701 | ||
| B09 EBV-B | 0301 | 2402 | 35 | 4402 | 05 | 04 | ||
| SK-OV-3 | 0301 | 6801 | 1801 | 3501 | 0401 | 0501 | + | |
| SK-MEL-29 | 0201 | 6801 | 4402 | 4501 | 0501 | 0602 | − | |
| SK-MEL-128 | 0101 | 2402 | 4402 | 5101 | 0102 | 0501 | + | |
| SK-MEL-37 | 0201 | 1101 | 1501 | 5601 | 0102 | + | ||
Bold number indicates HLA molecule matched with Patient B01. The bold underline indicates HLA molecule matched with both Patients B01 and B02
Serum Ab (+) NY-ESO-1 seropositive patient
Serum Ab (−) NY-ESO-1 seronegative patient
ESO (+) NY-ESO-1 expressing cell line
ESO (+) NY-ESO-1 nonexpressing cell line